Refractory cytopenia with multilineage dysplasia

{{Infobox medical condition (new)

| name = Refractory cytopenia with multilineage dysplasia

| synonyms =

| image =

| caption =

| pronounce =

| field = hematology

| symptoms =

| complications =

| onset =

| duration =

| types =

| causes =

| risks =

| diagnosis =

| differential =

| prevention =

| treatment =

| medication =

| prognosis =

| frequency =

| deaths =

}}

Refractory cytopenia with multilineage dysplasia is a form of myelodysplastic syndrome.{{Cite journal |vauthors=Rosati S, Mick R, Xu F, etal |title=Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome |journal=Leukemia |volume=10 |issue=1 |pages=20–6 |date=January 1996 |pmid=8558932 }}

It is abbreviated "RCMD".{{Cite journal|vauthors=Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D |title=Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden |journal=Biol. Blood Marrow Transplant. |volume=15 |issue=1 |pages=30–8 |date=January 2009 |pmid=19135940 |doi=10.1016/j.bbmt.2008.10.012 |doi-access=free }}{{Cite journal|vauthors=Hamdi W, Ogawara H, Handa H, Tsukamoto N, Nojima Y, Murakami H |title=Clinical significance of regulatory T cells in patients with myelodysplastic syndrome |journal=Eur. J. Haematol. |volume= 82|issue= 3|pages= 201–7|date=November 2008 |pmid=19018862 |doi=10.1111/j.1600-0609.2008.01182.x |s2cid=3519094 }}{{dead link|date=February 2019|bot=medic}}{{cbignore|bot=medic}}